SOLARIS Peripheral PMCF Trial

Inclusion Criteria: * Corresponding to the IFU indications/contra-indications and according to the current medical guidelines for minimally invasive peripheral interventions. * Patient presenting with a stenotic or occlusive lesion at the iliac arteries suitable for stenting (on indication for primary stenting, based on the discretion of the investigator) * Patient presenting a score from 2 to 5 following Rutherford classification * Patient is willing to comply with specified follow-up evaluations at the specified times for the duration of the study * Patient is \>18 years old * Patient (or their legal representative) understands the nature of the procedure and provides written informed consent, prior to enrolment in the study * The target lesion is either a modified TASC-II class A, B, C or D lesion. * The target lesion has angiographic evidence of stenosis or restenosis \> 50% or occlusion which can be passed with standard guidewire manipulation * There is angiographic evidence of a patent Common and Deep Femoral Artery Exclusion Criteria: * PTA is technically not possible (not feasible to access the lesion or a defect with the guidewire or balloon catheter) * Presence of an aneurysm immediately adjacent to the site of stent implantation * Stenosis distal to the site of stent implantation * Lesions in or adjacent to essential collaterals(s) * Lesions in locations subject to external compression * Heavily calcified lesions resistant to PTA * Patients with diffuse distal d…